跳至主要内容
临床试验/ACTRN12611000731998
ACTRN12611000731998终止未知

A randomized controlled trial of transcranial Direct Current Stimulation to reduce auditory hallucinations and enhance cognitive function in schizophrenia

niversity of New South Wales0 个研究点目标入组 40 人开始时间: 2011年7月13日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Patients will be included if they (1) are competent to give informed consent, as determined by the referring physician or psychiatrist, (2) have persistent symptoms despite treatment with antipsychotic medication for at least 12 months, and (3) are between 18 and 50 years of age.

排除标准

  • Patients will be excluded if (1) they are receiving carbamazepine since it may interfere with the effects of anodal tDCS, (2) have a history of substance abuse or dependence within the past year, (3) have a concomitant neurological disorder, or (4) they are pregnant. Patients will continue their regular medication regime for the duration of the tDCS treatment trial.

研究者

相似试验